Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression.
Gravas S, Manuel-Palacios J, Chavan C, Roehrborn CG, Oelke M, Averbeck MA, Biswas A, García LM, Mohamed K, Cortes V. Gravas S, et al. Among authors: chavan c. Prostate Cancer Prostatic Dis. 2024 Sep;27(3):469-477. doi: 10.1038/s41391-023-00731-w. Epub 2023 Oct 4. Prostate Cancer Prostatic Dis. 2024. PMID: 37794168 Free PMC article.
Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression.
D'Agate S, Chavan C, Manyak M, Palacios-Moreno JM, Oelke M, Michel MC, Roehrborn CG, Della Pasqua O. D'Agate S, et al. Among authors: chavan c. World J Urol. 2021 Jul;39(7):2635-2643. doi: 10.1007/s00345-020-03517-0. Epub 2020 Dec 18. World J Urol. 2021. PMID: 33337513 Free PMC article.
Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH.
D'Agate S, Wilson T, Adalig B, Manyak M, Palacios-Moreno JM, Chavan C, Oelke M, Roehrborn C, Della Pasqua O. D'Agate S, et al. Among authors: chavan c. World J Urol. 2020 Feb;38(2):463-472. doi: 10.1007/s00345-019-02783-x. Epub 2019 May 11. World J Urol. 2020. PMID: 31079189 Free PMC article. Clinical Trial.
Model-based meta-analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms.
D'Agate S, Wilson T, Adalig B, Manyak M, Palacios-Moreno JM, Chavan C, Oelke M, Roehrborn C, Della Pasqua O. D'Agate S, et al. Among authors: chavan c. Br J Clin Pharmacol. 2020 Aug;86(8):1585-1599. doi: 10.1111/bcp.14268. Epub 2020 Apr 14. Br J Clin Pharmacol. 2020. PMID: 32144791 Free PMC article.
Model-based meta-analysis of the time to first acute urinary retention or benign prostatic hyperplasia-related surgery in patients with moderate or severe symptoms.
D'Agate S, Chavan C, Manyak M, Palacios-Moreno JM, Oelke M, Michel MC, Roehrborn CG, Della Pasqua O. D'Agate S, et al. Among authors: chavan c. Br J Clin Pharmacol. 2021 Jul;87(7):2777-2789. doi: 10.1111/bcp.14682. Epub 2021 Jan 19. Br J Clin Pharmacol. 2021. PMID: 33247951 Free PMC article.
31 results